Menu
NutrEval is a comprehensive profile for identifying nutritional deficiencies and insufficiencies within patients. This is both a blood and urine profile that evaluates over 125 biomarkers and assesses the body’s functional need for 40 antioxidants, vitamins, minerals, essential fatty acids, amino acids, digestive support, and other select nutrients. This testing can address a wide range of patient concerns, from chronic health conditions to health optimization and peak performance. NutrEval is the only nutritional testing of its kind, combining several methodologies and biomarkers providing you with the most comprehensive nutritional assessment available.
The Immunoglobulin G (IgG) and Immunoglobulin E (IgE) Antibody Panels are blood tests that measure antibodies to commonly consumed foods and environmental allergens. The body can react to foods in many different ways. Adverse food reactions can lead to distressing symptoms and chronic health conditions. Often times it is unknown exactly which food(s) may be the cause and testing can help identify the problematic foods. Removal of the reactive foods often results in the resolution of symptoms.
The presence of circulating IgG antibodies to foods may be suggestive of increased intestinal permeability, also referred to as “leaky gut syndrome.” When the tight junctions forming the barrier in the gut don’t work properly, larger substances can “leak” through, causing an immune response. This immune response may result in the production of IgG antibodies to foods. There are multiple dietary and lifestyle factors that contribute to increased intestinal permeability. These factors include alcohol, stress, chronic NSAID use, a Western-type diet (high consumption of red meat, animal fat, high sugar, and low fiber food), and prolonged and strenuous exercise.
The Celiac Profile is a blood test that uses widely accepted immunologic biomarkers to aid in the diagnosis of Celiac disease (CD). Celiac disease is defined as an autoimmune enteropathy of the small intestine, caused by exposure to dietary gluten in genetically pre-disposed individuals. In susceptible individuals, gluten ingestion generates an inflammatory reaction predominantly centered in the upper parts of the small intestine. This mucosal injury will eventually reduce the intestinal absorptive area and interfere with the uptake of micronutrients.
For more information on Genesight testing, click here.
BRACAnalysis CDx is an FDA-approved test used to identify patients with germline BRCA1/2 mutations who may be eligible for certain targeted therapies without delay. This test quickly and accurately provides results for patients with pancreatic cancer, breast cancer, ovarian cancer, and prostate cancer who may benefit from PARP inhibitor treatment. For more information on cancer risk assessments
